Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

WASHINGTON, Aug. 18, 2025 /PRNewswire/ — Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions (“Evolent”), today announced that it intends to offer $140.0 million aggregate principal amount of convertible senior notes…